Evidence map›Paper›PMID 35205883›Full record

ReviewJournal of fungi (Basel, Switzerland)2022

Adélaïde Chesnay, Christophe Paget, Nathalie Heuzé-Vourc'h, Thomas Baranek, Guillaume Desoubeaux

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CD40 Expression by B cells is Required for Optimal Immunity to MurinebioRxiv : the preprint server for biology · 2024
    Article
  5. Genetic Mouse Models of Pneumocystis Pneumonia.Methods in molecular biology (Clifton, N.J.) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Adélaïde ChesnayService de Parasitologie-Mycologie-Médecine Tropicale, Pôle Biologie Médicale, Hôpital Bretonneau, CHRU de Tours, 2 Boulevard Tonnellé, 37044 Tours, France.ORCID 0000-0001-6218-2442
Christophe PagetCentre d'Etude des Pathologies Respiratoires (CEPR), Institut National de la Santé et de la Recherche Médicale U1100, Université de Tours, 10 Bouelvard Tonnellé, 37032 Tours, France.
Nathalie Heuzé-Vourc'hCentre d'Etude des Pathologies Respiratoires (CEPR), Institut National de la Santé et de la Recherche Médicale U1100, Université de Tours, 10 Bouelvard Tonnellé, 37032 Tours, France.ORCID 0000-0003-4929-5068
Thomas BaranekCentre d'Etude des Pathologies Respiratoires (CEPR), Institut National de la Santé et de la Recherche Médicale U1100, Université de Tours, 10 Bouelvard Tonnellé, 37032 Tours, France.
Guillaume DesoubeauxService de Parasitologie-Mycologie-Médecine Tropicale, Pôle Biologie Médicale, Hôpital Bretonneau, CHRU de Tours, 2 Boulevard Tonnellé, 37044 Tours, France.
Université de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

animal modelinfectious challengein vivoPneumocystis pneumoniaPneumocystis spp.

Identifiers

PMID35205883
PMCPMC8877242
OpenAlexW4210517845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.